Unresectable Melanoma
Oncology·MeSH: Skin Neoplasms
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
7 drugs in development·2 companies·17 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| amtagvi | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) |
Phase 1(3)
Unknown(1)
Phase 1/Phase 2(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Unresectable Melanoma?
BioSniper tracks 7 drugs in development for Unresectable Melanoma across 2 companies.
How many clinical trials target Unresectable Melanoma?
There are 17 clinical trials targeting Unresectable Melanoma tracked by BioSniper.
What is the prevalence of Unresectable Melanoma?
The estimated prevalence of Unresectable Melanoma is approximately 75.0 per 100,000 population.
Deep-dive into Unresectable Melanoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis